-
- Nov 20/24
From one gene switch, many possible outcomes - Nov 19/24
Neurogene drops Batten gene therapy program - Nov 19/24
Cell density impacts engineering of synthetic multicellular structures for regenerative medicine - Nov 19/24
By exerting “crowd control” over mouse cells, scientists make progress towards engineering tissues - Nov 18/24
Architect of neural circuits plays unexpected role in spinal cord development - Nov 18/24
FDA endorses speedy approval path for Regenxbio Duchenne gene therapy - Nov 18/24
Celebrating a milestone in gene therapy for sickle cell disease - Nov 18/24
Personalized bone and tissue regeneration gel shows effectiveness in rats - Nov 18/24
Neurogene rethinks gene therapy trial after high dose leaves Rett patient in critical condition - Nov 17/24
A new approach in Usher syndrome gene therapy - Nov 17/24
Weekly reads: stem cell therapy for vision loss, cancer self-experimentation, Slovenia, 14-day rule - Nov 15/24
Scientists develop novel plug-and-play test to evaluate T cell immunotherapy effectiveness - Nov 15/24
University of Cincinnati research studies new technique to visualize CAR T-cells within the body - Nov 15/24
Recording cancer cells from the inside - Nov 15/24
Blood becomes medicine in a revolutionary regeneration breakthrough - Nov 14/24
UBC, Genome BC, and STEMCELL partner to advance stem cell therapies - Nov 14/24
Adaptimmune nears second approval for TCR-T therapy - Nov 14/24
PTC wins first FDA nod for direct-to-brain gene therapy, targets ultrarare disease - Nov 14/24
Empowering the nervous system to repair itself - Nov 13/24
Next-gen CAR-T therapy: innovations, challenges and future directions - Nov 13/24
CAR T cell therapy breakthroughs bring new hope for treating solid tumours - Nov 13/24
Rejuvenating lung stem cells for idiopathic pulmonary fibrosis - Nov 13/24
Gene therapy protects rats from motor neuron disease - Nov 12/24
Neurogene gene therapy shows signs of efficacy in small study, but an adverse event spooks investors - Nov 12/24
UAB researchers cure liver disease MASH by a one-time gene therapy - Nov 12/24
CAR T-cell therapy recruits brain’s defenses against glioblastoma - Nov 12/24
Bayer drops Huntington’s gene therapy to focus on ‘most promising assets’ - Nov 12/24
Patient-derived organoids: Transforming cancer research and personalized medicine - Nov 11/24
ISSCR creates first-of-its kind continuing education course on stem cell-based medicine - Nov 11/24
Largest T cell clinical trial in solid tumours heralds new era in precision immunotherapy - Nov 11/24
Autolus secures FDA approval for CAR-T cell therapy use in ALL - Nov 11/24
Gene editing sector investment struggles: What’s driving the slowdown? - Nov 11/24
CQDM, Brain Canada and industry partners join forces to address unmet medical needs in the treatment of brain disorders - Nov 10/24
New take on immunotherapy reinvigorates T cells by blocking uptake of energy-sapping cancer byproducts - Nov 9/24
Unusual stem cell discovery challenges longstanding cellular reprogramming theories - Nov 9/24
CAR T-cell therapy for kidney cancer builds on efficacy record - Nov 8/24
Advancing heart stem cell therapy - Nov 8/24
World-first stem-cell treatment restores vision in people - Nov 7/24
Nasal spray made from stem cell-derived vesicles could treat Alzheimer’s disease - Nov 7/24
Researchers are one step closer to developing cell-based therapy for hypothyroidism - Nov 7/24
Sarepta scraps a Duchenne drug as gene therapy sales rise - Nov 6/24
How to overcome immune rejection in iPSC-based gene therapy - Nov 6/24
Parallel platform approach slashes process development time - Nov 6/24
How this ‘switchable’ CAR-T therapy sets its sights on deadly brain cancer - Nov 6/24
Ring Therapeutics calls on Singapore research agencies for gene therapy R&D partnership - Nov 6/24
Sickle cell patient dies in gene-therapy trial - Nov 6/24
Gene editing with CRISPR may introduce new defects - Nov 6/24
Stem cells can tailor their role in gene therapy based on the underlying disease, study suggests - Nov 6/24
Allogeneic: The next stage for the cell therapy story - Nov 5/24
On the cusp of a CAR T cell cure for lupus - Nov 5/24
Unlocking AAV gene therapy potential: The role of successful characterization - Nov 4/24
Space-grown stem cells show promise for accelerating biotherapies - Nov 4/24
FDA lifts clinical holds placed on 3 CAR T-cell therapy trials - Nov 4/24
CAR T and related therapies home in on autoimmune disease - Nov 2/24
How a breakthrough gene-editing tool will help the world cope with climate change - Nov 1/24
Stem cell finding casts doubt on popular theory of direct reprogramming - Nov 1/24
‘It was a good lesson’: FDA reconsiders CAR-T boxed warning on secondary cancers, Peter Marks says
- Nov 20/24
